AKERS BIOSCIENCES INC's ticker is AKER and the CUSIP is 00973E102. A total of 12 filers reported holding AKERS BIOSCIENCES INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $771,000 | -23.1% | 2,715,817 | +5.0% | 0.00% | – |
| Q2 2018 | $1,002,000 | -52.9% | 2,587,678 | +0.7% | 0.00% | – |
| Q1 2018 | $2,127,000 | +23533.3% | 2,569,301 | +3654.9% | 0.00% | – |
| Q4 2017 | $9,000 | -84.2% | 68,425 | -2.7% | 0.00% | – |
| Q3 2017 | $57,000 | -37.4% | 70,325 | 0.0% | 0.00% | – |
| Q2 2017 | $91,000 | +122.0% | 70,325 | +179.9% | 0.00% | – |
| Q1 2016 | $41,000 | -45.3% | 25,127 | -59.6% | 0.00% | – |
| Q4 2015 | $75,000 | -100.0% | 62,254 | -98.7% | 0.00% | -100.0% |
| Q3 2015 | $186,077,000 | +68563.1% | 4,782,787 | +7582.7% | 0.01% | – |
| Q2 2015 | $271,000 | +5.9% | 62,254 | +3.1% | 0.00% | – |
| Q1 2015 | $256,000 | +6.2% | 60,354 | 0.0% | 0.00% | – |
| Q4 2014 | $241,000 | +10.6% | 60,354 | 0.0% | 0.00% | – |
| Q3 2014 | $218,000 | -14.2% | 60,354 | 0.0% | 0.00% | – |
| Q2 2014 | $254,000 | -7.6% | 60,354 | 0.0% | 0.00% | – |
| Q1 2014 | $275,000 | – | 60,354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 95,700 | $408,000 | 0.29% |
| BARD ASSOCIATES INC | 90,000 | $383,000 | 0.15% |
| LMR Partners LLP | 136,342 | $574,000 | 0.05% |
| COMMERZBANK AKTIENGESELLSCHAFT /FI | 83,655 | $356,000 | 0.00% |
| OPPENHEIMER & CO INC | 10,700 | $46,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,921 | $8,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 500 | $2,130,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,605 | $7,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 2,005 | $9,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 200 | $1,000 | 0.00% |